Over the past 12 months, 5 insiders at HALOZYME THERAPEUTICS, INC. filed 74 open-market SEC Form 4 transactions on HALO: 0 purchases worth $0 and 74 sales worth $31.0M. Insiders have been net sellers over this period. The most recent filing was on Jul 8, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 8, 26 | Helen TorleyPRESIDENT AND CEO | SELL | 1.0K | $80.19 | $83K |
| Jul 1, 26 | Bernadette Connaughton | SELL | 1.0K | $77.21 | $76K |
| Jun 29, 26 | Mahesh Krishnan | SELL | 7.3K | $75.00 | $548K |
| Jun 1, 26 | Bernadette Connaughton | SELL | 1.6K | $66.21 | $108K |
| May 1, 26 | Bernadette Connaughton | SELL | 1.6K | $63.48 | $103K |
| Mar 10, 26 | Cortney CaudillSVP, CHIEF OPERATING OFFICER | SELL | 8.9K | $67.64 | $599K |
| Mar 9, 26 | Cortney CaudillSVP, CHIEF OPERATING OFFICER | SELL | 17.9K | $68.25 | $1.2M |
| Mar 4, 26 | Helen TorleyPRESIDENT AND CEO | SELL | 7.3K | $70.95 | $513K |
| Mar 3, 26 | Helen TorleyPRESIDENT AND CEO | SELL | 13.5K | $69.33 | $928K |
| Mar 2, 26 | Helen TorleyPRESIDENT AND CEO | SELL | 15.3K | $70.46 | $1.1M |
| Feb 5, 26 | Helen TorleyPRESIDENT AND CEO | SELL | 5.4K | $78.94 | $421K |
| Feb 4, 26 | Helen TorleyPRESIDENT AND CEO | SELL | 10.1K | $77.54 | $783K |
| Feb 3, 26 | Helen TorleyPRESIDENT AND CEO | SELL | 9.7K | $76.73 | $734K |
| Jan 5, 26 | Bernadette ConnaughtonDirector | SELL | 2.0K | $70.25 | $141K |
| Dec 1, 25 | Bernadette ConnaughtonDirector | SELL | 829 | $71.60 | $59K |
| Dec 1, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 10.4K | $71.60 | $713K |
| Nov 12, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 12.7K | $71.67 | $893K |
| Nov 11, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 11.5K | $69.73 | $802K |
| Nov 10, 25 | Bernadette ConnaughtonDirector | SELL | 2.0K | $68.48 | $137K |
| Nov 10, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 19.9K | $69.30 | $1.4M |
| Nov 1, 25 | Cortney CaudillSVP, CHIEF OPERATING OFFICER | SELL | 4.3K | $65.19 | $278K |
| Oct 3, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 14.2K | $71.67 | $975K |
| Oct 2, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 10.2K | $74.67 | $727K |
| Oct 1, 25 | Bernadette ConnaughtonDirector | SELL | 1.5K | $75.70 | $113K |
| Oct 1, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 11.7K | $75.69 | $879K |
| Sep 22, 25 | Nicole LabrosseSVP, CHIEF FINANCIAL OFFICER | SELL | 1.9K | $78.67 | $149K |
| Sep 10, 25 | Nicole LabrosseSVP, CHIEF FINANCIAL OFFICER | SELL | 13.2K | $75.93 | $1.0M |
| Sep 4, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 9.9K | $75.22 | $728K |
| Sep 3, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 10.5K | $74.63 | $784K |
| Sep 2, 25 | Bernadette ConnaughtonDirector | SELL | 3.0K | $74.11 | $219K |
| Sep 2, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 16.3K | $74.15 | $1.2M |
| Aug 13, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 14.9K | $64.83 | $959K |
| Aug 12, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 13.0K | $64.00 | $825K |
| Aug 11, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 18.7K | $63.60 | $1.2M |
| Jul 10, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 15.7K | $57.62 | $907K |
| Jul 9, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 19.8K | $57.08 | $1.1M |
| Jul 8, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 16.4K | $55.74 | $914K |
| Jun 24, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 15.5K | $53.91 | $836K |
| Jun 23, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 20.0K | $52.57 | $1.1M |
| Jun 20, 25 | Helen TorleyPRESIDENT AND CEO | SELL | 20.0K | $52.96 | $1.1M |
| Apr 28, 25 | Jeffrey William HendersonDirector | SELL | 4.3K | $61.00 | $259K |
| Apr 1, 25 | Jeffrey William HendersonDirector | SELL | 503 | $64.05 | $32K |
| Mar 3, 25 | Jeffrey William HendersonDirector | SELL | 3.2K | $59.12 | $189K |
| Feb 27, 25 | Michael J. LabarreSVP, CHIEF TECHNICAL OFFICER | SELL | 1.6K | $58.74 | $93K |
| Feb 26, 25 | Michael J. LabarreSVP, CHIEF TECHNICAL OFFICER | SELL | 9.4K | $58.65 | $546K |
| Feb 25, 25 | Michael J. LabarreSVP, CHIEF TECHNICAL OFFICER | SELL | 9.3K | $58.67 | $539K |
| Feb 3, 25 | Jeffrey William HendersonDirector | SELL | 3.9K | $56.41 | $220K |
| Jan 6, 25 | Jeffrey William HendersonDirector | SELL | 10.0K | $50.01 | $500K |
| Oct 16, 24 | Michael J. LabarreSVP, CHIEF TECHNICAL OFFICER | SELL | 10.0K | $53.26 | $533K |
| Oct 15, 24 | Michael J. LabarreSVP, CHIEF TECHNICAL OFFICER | SELL | 9.9K | $54.25 | $533K |
Over the past 12 months, insiders at HALOZYME THERAPEUTICS, INC. filed 0 open-market purchases worth $0 and 74 sales worth $31.0M on HALO, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 8, 26.
5 different insiders at HALOZYME THERAPEUTICS, INC. filed open-market SEC Form 4 transactions on HALO over the last 12 months.
InsiderTape plots every HALO insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every HALOZYME THERAPEUTICS, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →